A share price of DENTSPLY Sirona Inc [XRAY] is currently trading at $15.91, down -0.87%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The XRAY shares have gain 2.05% over the last week, with a monthly amount drifted -15.19%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DENTSPLY Sirona Inc [NASDAQ: XRAY] stock has seen the most recent analyst activity on February 14, 2025, when Wells Fargo initiated its Equal Weight rating and assigned the stock a price target of $20. Previously, Jefferies downgraded its rating to Hold on January 23, 2025, and dropped its price target to $20. On January 07, 2025, downgrade downgraded it’s rating to In-line but maintained its price target of $20 on the stock. Mizuho started tracking the stock assigning a Neutral rating and suggested a price target of $21 on December 04, 2024. Leerink Partners downgraded its rating to a Market Perform. Needham reiterated a Buy rating for this stock on October 25, 2024, and downed its price target to $29. In a note dated August 20, 2024, Needham reiterated an Buy rating on this stock but restated the target price of $34.
DENTSPLY Sirona Inc experienced fluctuations in its stock price throughout the past year between $15.47 and $34.28. Currently, Wall Street analysts expect the stock to reach $19.5 within the next 12 months. DENTSPLY Sirona Inc [NASDAQ: XRAY] shares were valued at $15.91 at the most recent close of the market. An investor can expect a potential return of 22.56% based on the average XRAY price forecast.
Analyzing the XRAY fundamentals
Trailing Twelve Months sales for DENTSPLY Sirona Inc [NASDAQ:XRAY] were 3.79B which represents -10.57% decline. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -0.23%, Pretax Profit Margin comes in at -0.25%, and Net Profit Margin reading is -0.24%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.34 and Total Capital is -0.21. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.62 points at the first support level, and at 15.33 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.11, and for the 2nd resistance point, it is at 16.31.
Ratios To Look Out For
To put it in perspective, the Current Ratio for DENTSPLY Sirona Inc [NASDAQ:XRAY] is 1.10. Further, the Quick Ratio stands at 0.74, while the Cash Ratio is 0.17. Considering the valuation of this stock, the price to sales ratio is 0.83, the price to book ratio is 1.63.
Transactions by insiders
Recent insider trading involved LUCIER GREGORY T, Director, that happened on Mar 03 ’25 when 15142.0 shares were purchased. Former Officer, Coleman Glenn completed a deal on Jan 27 ’25 to buy 15759.0 shares. Meanwhile, Director LUCIER GREGORY T bought 5000.0 shares on Nov 18 ’24.
